Health Condition 1: J30- Vasomotor and allergic rhinitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: i. Perennial Allergic Rhinitis patients with serum 25 (OH)-Vitamin-D3 levels less than 20 ng/ml. ii. Patients who will give informed consent for participation in the study.
Exclusion criteria
Exclusion criteria: i. Associated Nasal co-morbidities like Nasal Polyposis, Sinusitis, Deviated Nasal Septum, Autoimmune disease of nose. ii. Associated Systemic co-morbidities affecting vitamin D levels like Juvenile Idiopathic Arthritis, Rickets, Cystic Fibrosis, Ulcerative Colitis, Crohn’s disease, Celiac disease, Thyroid dysfunction. iii. Individuals who had received medications including corticosteroids, barbiturates, bisphosphonates, omega-3 fatty acids, anti-epileptics and vitamin D. iv. Pregnant and breastfeeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in TEC levels, TNSS score and RCAT score with Vitamin D supplementationTimepoint: Baseline(at 0 weeks), 4 weeks and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Better understanding of the relation between serum vitamin D levels & symptom severity of perennial allergic rhinitis.Timepoint: Baseline(at 0 weeks), 4 weeks & 8 weeks | — |
Countries
India
Contacts
Geetanjali Medical College and Hospital